By Suchitra Mukherjee
New Delhi, May 27 -- rector General of the Council of Scientific and Industrial Research (CSIR), Shekher Mande, on Wednesday said the Indian Council of Medical Research's (ICMR) conclusion of hydroxychloroquine (HCQ) having no major side-effects in the treatment of Covid-infected patients should be trusted.
Indian researchers have not found any major side-effects of HCQ and its use should be continued in preventive treatment for COVID-19, the Indian Council of Medical Research (ICMR) said on Tuesday.
"We should trust the judgement of ICMR. ICMR people are exceptionally well qualified in this. If they say it should be continued we should trust their judgement and will continue this drug," Mande told ANI.
The WHO, on...